-
Signature
-
/s/ Christian Kuhlen, attorney-in-fact
-
Issuer symbol
-
ORIC
-
Transactions as of
-
24 Feb 2026
-
Net transactions value
-
-$475,966
-
Form type
-
4
-
Filing time
-
26 Feb 2026, 16:47:24 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Piscitelli Dominic |
Chief Financial Officer |
C/O ORIC PHARMACEUTICALS, INC., 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO |
/s/ Christian Kuhlen, attorney-in-fact |
26 Feb 2026 |
0001695028 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ORIC |
Common Stock |
Options Exercise |
$226,720 |
+52,000 |
+76% |
$4.36 |
120,148 |
24 Feb 2026 |
Direct |
|
| transaction |
ORIC |
Common Stock |
Sale |
$702,686 |
-52,000 |
-43% |
$13.51 |
68,148 |
24 Feb 2026 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ORIC |
Stock Option (right to buy) |
Options Exercise |
$0 |
-52,000 |
-26% |
$0.000000 |
144,500 |
24 Feb 2026 |
Common Stock |
52,000 |
$4.36 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: